glp 1 based therapies GLP-1-based for diabetes, obesity and beyond Real-world data from electronic health

for gastric or gastroesophageal junction cancer, according to Astellas

Seek immediate medical attention if you experience: marked hyperglycemia (persistent glucose 300 mg/dL), dehydration, confusion, vomiting, unexplained weight loss, excessive urination, extreme thirst, or signs of diabetic ketoacidosis (abdominal pain, rapid breathing, fruity breath odor)

Notably, elevated ROS levels also play a pivotal role in non-parenchymal cell damage within the digestive system, as exemplified in PHG associated with cirrhosis [368, 369]

Ozempic alternatives for type 2 diabetes As of 2026, six other GLP-1 medications are approved for the treatment of type 2 diabetes: Rybelsus (semaglutide), Mounjaro (tirzepatide), Trulicity (dulaglutide), Victoza (liraglutide), Bydureon BCise (exenatide) and Byetta (exenatide)

It also helps to lower the risk of chronic diseases, including neurodegenerative conditions and mental health issues